DNA origami-based vaccines toward safe and highly-effective precision cancer immunotherapy
Therapeutic cancer vaccines are a form of immunotherapy in the making that could not only…
Browsing: neoantigens
Immuno-oncology collaboration to develop innovative new type of cancer drug
Scientists at The Institute of Cancer Research, London, UK, are teaming up with small molecule…
Study modeling tumour evolution reveals a vulnerability for cancer prevention and therapy
Though the mutations accumulated by cancer cells occur more or less randomly, certain regions of…
Immune ‘cloaking’ in cancer cells and implications for immunotherapy
Researchers at Queen Mary University of London, The Institute of Cancer Research, London, UK, and…
Anticancer vaccines gain new lease of life with personalisation techniques
Anticancer vaccines have gained a new lease of life with techniques to personalise them to…
Personal cancer vaccines show positive results
Immunotherapies are moving to the forefront of cancer treatment. Recent clinical trials have demonstrated that…
Personal neoantigen vaccine prompts strong anti-tumour response in melanoma patients
A personal cancer treatment vaccine that targets distinctive “neoantigens” on tumour cells has been shown…